Page last updated: 2024-11-02

pd 98059 and Animal Mammary Carcinoma

pd 98059 has been researched along with Animal Mammary Carcinoma in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research Excerpts

ExcerptRelevanceReference
"[1986] Invasion Metastasis 6:302-12; Urtreger et al."1.31Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells. ( Aguirre Ghiso, J; Bal de Kier Joffé, E; Balañá, ME; Charreau, EH; Elizalde, PV; Labriola, L; Lupu, R; Pignataro, OP; Proietti, CJ; Proiettii, CJ; Puricelli, L; Salatino, M, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Puricelli, L1
Proietti, CJ1
Proiettii, CJ1
Labriola, L1
Salatino, M1
Balañá, ME1
Aguirre Ghiso, J1
Lupu, R1
Pignataro, OP1
Charreau, EH1
Bal de Kier Joffé, E1
Elizalde, PV1

Other Studies

1 other study available for pd 98059 and Animal Mammary Carcinoma

ArticleYear
Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
    International journal of cancer, 2002, Aug-20, Volume: 100, Issue:6

    Topics: Animals; Blotting, Western; Cell Division; Cell Movement; Dimerization; Dose-Response Relationship,

2002